US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21703, USA.
Center of Biologics Evaluation and Research, US Food and Drug Administration, Bethesda, MD 20892, USA.
J Immunol Res. 2014;2014:341820. doi: 10.1155/2014/341820. Epub 2014 Jun 4.
The current candidate vaccine against Yersinia pestis infection consists of two subunit proteins: the capsule protein or F1 protein and the low calcium response V protein or V-antigen. Little is known of the recognition of the vaccine by the host's innate immune system and how it affects the acquired immune response to the vaccine. Thus, we vaccinated Toll-like receptor (Tlr) 2, 4, and 2/4-double deficient, as well as signal adaptor protein Myd88-deficient mice. We found that Tlr4 and Myd88 appeared to be required for an optimal immune response to the F1-V vaccine but not Tlr2 when compared to wild-type mice. However, there was a difference between the requirement for Tlr4 and MyD88 in vaccinated animals. When F1-V vaccinated Tlr4 mutant (lipopolysaccharide tolerant) and Myd88-deficient mice were challenged by aerosol with Y. pestis CO92, all but one Tlr4 mutant mice survived the challenge, but no vaccinated Myd88-deficient mice survived the challenge. Spleens from these latter nonsurviving mice showed that Y. pestis was not cleared from the infected mice. Our results suggest that MyD88 appears to be important for both an optimal immune response to F1-V and in protection against a lethal challenge of Y. pestis CO92 in F1-V vaccinated mice.
荚膜蛋白或 F1 蛋白和低钙反应 V 蛋白或 V 抗原。宿主固有免疫系统对疫苗的识别及其如何影响疫苗的获得性免疫反应知之甚少。因此,我们对 Toll 样受体(Tlr)2、4 和 2/4 双缺失以及信号衔接蛋白 Myd88 缺失的小鼠进行了疫苗接种。我们发现,与野生型小鼠相比,Tlr4 和 Myd88 似乎是对 F1-V 疫苗产生最佳免疫反应所必需的,但 Tlr2 并非如此。然而,在接种疫苗的动物中,Tlr4 和 MyD88 的需求存在差异。当用鼠疫耶尔森菌 CO92 气溶胶对 F1-V 接种的 Tlr4 突变(耐受脂多糖)和 Myd88 缺失的小鼠进行挑战时,除了一只 Tlr4 突变小鼠外,所有小鼠都存活下来,但没有接种 Myd88 缺失的小鼠存活下来。来自这些后一组未存活小鼠的脾脏表明,鼠疫耶尔森菌未从感染小鼠中清除。我们的结果表明,MyD88 似乎对 F1-V 的最佳免疫反应和对 F1-V 接种的鼠疫耶尔森菌 CO92 致死性挑战的保护都很重要。